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BACKGROUND: Accurate gestational age estimation is extremely dataset. Gestational age was predicted within 1 week for 78% of the in-
important for clinical care decisions of the newborn as well as for perinatal
health research. Although prenatal ultrasound dating is one of the most
accurate methods for estimating gestational age, it is not feasible in all
settings. Identifying novel and accurate methods for gestational age
estimation at birth is important, particularly for surveillance of preterm
birth rates in areas without routine ultrasound dating.
OBJECTIVE: We hypothesized that metabolic and endocrine markers
captured by routine newborn screening could improve gestational age
estimation in the absence of prenatal ultrasound technology.
STUDY DESIGN: This is a retrospective analysis of 230,013 newborn
metabolic screening records collected by the Iowa Newborn Screening
Program between 2004 and 2009. The data were randomly split into a
model-building dataset (n ¼ 153,342) and a model-testing dataset
(n ¼ 76,671). We performed multiple linear regression modeling with
gestational age, in weeks, as the outcome measure. We examined 44
metabolites, including biomarkers of amino acid and fatty acid meta-
bolism, thyroid-stimulating hormone, and 17-hydroxyprogesterone. The
coefficient of determination (R2) and the root-mean-square error were
used to evaluate models in the model-building dataset that were then
tested in the model-testing dataset.
RESULTS: The newborn metabolic regression model consisted of 88
parameters, including the intercept, 37 metabolite measures, 29 squared
metabolite measures, and 21 cubed metabolite measures. This model
explained 52.8% of the variation in gestational age in the model-testingCite this article as: Ryckman KK, Berberich SL, Dagle JM.
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http://dx.doi.org/10.1016/j.ajog.2015.11.028dividuals and within 2 weeks of gestation for 95% of the individuals. This
model yielded an area under the curve of 0.899 (95% confidence interval
0.8950.903) in differentiating those born preterm (<37 weeks) from
those born term (37 weeks). In the subset of infants born small-for-
gestational age, the average difference between gestational ages pre-
dicted by the newborn metabolic model and the recorded gestational age
was 1.5 weeks. In contrast, the average difference between gestational
ages predicted by the model including only newborn weight and the
recorded gestational age was 1.9 weeks. The estimated prevalence of
preterm birth <37 weeks’ gestation in the subset of infants that were
small for gestational age was 18.79% when the model including only
newborn weight was used, over twice that of the actual prevalence of
9.20%. The newborn metabolic model underestimated the preterm birth
prevalence at 6.94% but was closer to the prevalence based on the
recorded gestational age than the model including only newborn weight.
CONCLUSIONS: The newborn metabolic profile, as derived from
routine newborn screening markers, is an accurate method for estimating
gestational age. In small-for-gestational age neonates, the newborn
metabolic model predicts gestational age to a better degree than newborn
weight alone. Newborn metabolic screening is a potentially effective
method for population surveillance of preterm birth in the absence of
prenatal ultrasound measurements or newborn weight.
Key words: fetal growth, neonatal metabolism, preterm birthccurate estimation of gestationalA age is important for perinatal care
and research. Clinically, predicting
gestational age during pregnancy is
important for determining the treatment
and management of pregnancies that
may end in preterm birth (<37 weeks’
completed gestation). Preterm birth is
the leading cause of child death, ahead of
infectious disease, worldwide with the
greatest rates in low-resource regions
such as West Africa.1 Population esti-
mates of gestational age are extremely
important for determining the burden ofpreterm birth and small-for-gestational
age, particularly in low-resource set-
tings.1 Accurate gestational age estimates
are necessary for identifying the causes
and risk factors for preterm birth and
small-for-gestational age as well as eval-
uating interventions that may be used
to prevent these conditions in the
future. Identifying areas with greater-
than-average preterm and small-for-
gestational age rates can aid health
professionals in targeting interventions
where they would have the largest
impact.
There are several methods commonly
used for estimating gestational age dur-
ing pregnancy. One such method,
ultrasound dating, is based on estimating
gestational age by measuring the size of
the fetus in early pregnancy. Another
commonly used method, particularly in
areas without access to ultrasound
technologies, is estimating gestational
length based on a woman’s lastAPRIL 2016 Amerimenstrual period. Last menstrual period
often is inferior to ultrasound dating,
because it relies on a woman remem-
bering the date of her last menstrual
cycle.2-4 Although ultrasound dating is
becoming increasingly common in the
United States, it is not currently practical
in most developing regions of the world
or for women receiving little or no pre-
natal care. Gestational age dating by fetal
ultrasound also is not robust for neo-
nates who are small or large for their
gestational age.5,6
For underdeveloped areas in which
women do not have access to prenatal
care, gestational age can be estimated
after birth. Dubowitz or Ballard exami-
nations estimate gestational age by the
use of standardized scoring systems
based on physical and neuromuscular
characteristics of the newborn infant.7,8
Gestational age estimates based on
either the Dubowitz or Ballard criteria
are less precise than obstetriccan Journal of Obstetrics& Gynecology 515.e1
Original Research OBSTETRICS ajog.orgestimates.9,10 In fact, neonatal-derived
gestational age estimates most often
overestimate the number of infants born
less than 40 weeks’ gestation while
underestimating the number of infants
born at or greater than 40 weeks’ gesta-
tion.9,10 Birthweight also can be used to
estimate gestational age but is limited in
the same way as neonatal examinations
and is not robust in small- or large-for-
gestational age infants.11
Gestational age is correlated strongly
with many developmental andmetabolic
processes and is a strong predictor of
neonatal outcome.12 Several studies have
demonstrated altered maternal and cord
blood amino acid and fatty acid metab-
olites in pregnancies that end in preterm
birth or the birth of a low birthweight or
small for gestational age neonate.13-15 In
addition, there are distinct urinary
metabolic patterns in preterm neonates
compared with their term counter-
parts.16 We and others have shown that
metabolites related to amino acid and
fatty acid metabolism measured 2472
hours after birth are vastly different
among very preterm (<32 weeks),
moderately preterm (3236), and term
(37 weeks) neonates.17,18 Newborn
metabolic screening via the use of tan-
dem mass spectrometry has long been
recognized as a critical public health
initiative to identify mostly treatable but
individually rare inborn errors of meta-
bolism.19 Newborn metabolic screening
captures data from a variety of bio-
markers, including amino acids, free
carnitine, and acylcarnitines. We hy-
pothesized that metabolic and endocrine
markers captured by routine neonatal
screening could improve gestational age
estimation in the absence of prenatal
ultrasound technology. This technique
would have practical application for
surveillance of preterm birth at a popu-
lation level when prenatal care is limited.
Materials and Methods
Study population
We performed a retrospective analysis
of 238,315 newborn metabolic screen-
ing records collected by the Iowa
Newborn Screening Program between
2004 and 2009. Forty-four metabolites
were measured on all subjects during515.e2 American Journal of Obstetrics& Gynecolthe entire study period, including 2
enzymes (biotinidase and galactose-
1-phosphate uridyl transferase), 2
hormones (thyroid-stimulating hormone
[TSH] and 17-hydroxyprogesterone [17-
OHP]), 9 amino acids, 30 acylcarnitines,
and free carnitine (C0) (Supplementary
Table 1). Blood spot specimens were
collected, dried, and handled as part of
routine clinical care according to the
Clinical Laboratory Standards Institute
guidelines.20 At the time of neonatal
screening, the health care provider re-
cords the gestational age in weeks, the sex
of the infant, current weight in grams, if
the infant is currently on total parenteral
nutrition, and age of the newborn in
hours. This information is included
with each newborn screening specimen.
Data such as delivery mode or maternal
characteristics were not available. The
method of gestational dating, ie, last
menstrual period or fetal ultrasound, is
provider dependent and is not distin-
guished on the newborn screen record.
All specimens were analyzed as part of
the Iowa Newborn Screening Program
by the State Hygienic Laboratory in
Ankeny, Iowa. Screening procedures in
Iowa are based on previously established
methodology.18,19
The State Hygienic Laboratory iden-
tiﬁed multiple gestations by examining
birth date, gestational age, mother’s ﬁrst
name, and facility identiﬁcation number.
The data were deidentiﬁed by the State
Hygienic Laboratory and provided for
use in this study. Approval for use of the
deidentiﬁed data was obtained from the
Iowa Department of Public Health and a
waiver of consent from the Institutional
Review Board at the University of Iowa
(IRB#200908793).
Only initial newborn screening spec-
imens, not repeats, were included in the
analysis. We excluded screening records
with missing gestational age data (n ¼
5749) or those with a recorded gesta-
tional age day outside the range of 2045
completed weeks (n ¼ 108). Records for
specimens that were rejected by the
screening laboratory as being of poor
quality (n ¼ 2445) were excluded from
analysis. The remaining dataset con-
sisted of 230,013 neonatal metabolic
screening records. To determine the ﬁnalogy APRIL 2016performance of the predictive model, the
data were randomly split into a model-
building dataset (n ¼ 153,342) and a
model-testing dataset (n ¼ 76,671). The
predictive model was created using the
model-building dataset and the perfor-
mance of this model was then evaluated
in the model-testing dataset.
Statistical analysis
Univariate analysis was performed with
each metabolite and gestational age.
Linearity between gestational age and
single metabolite levels was inspected
visually by plots of the residuals vs the
predicted values. To address nonlinearity
between each metabolite and gestational
age, squared terms and then the cubed
terms were included for each model. We
performed multiple linear regression
modeling with gestational age, in weeks,
as the outcome measure, using metabo-
lites that were signiﬁcant in the univar-
iate analysis. The regression was
estimated by the use of ordinary least
squares. In the model-building dataset,
all metabolites signiﬁcant at P<.01 from
the univariate models were included in
the initial model, and signiﬁcant terms
(P < .05) were retained for subsequent
modeling. Squared and cubed terms of
signiﬁcant metabolites were included
successively in the model after which
nonsigniﬁcant (P > .05) terms were
removed. Cubic terms were examined
only when squared terms were
signiﬁcant.
Next, within the model-building
dataset, we determined whether the
ﬁnal selected model was robust in the
presence of covariates that could affect
the prediction of gestational age by the
metabolic panel. These covariates
included the child’s sex, age at time of
sample collection (in hours, month, and
year of sample collection), neonatal
weight at time of screening in grams,
weight for gestational age categorized
as small-for-gestational age (<10th
percentile for each gestational age
week), large-for-gestational age (>90th
percentile for each gestational age week),
and average-for-gestational age and
multiple gestation. Residuals vs the pre-
dicted values were inspected visually for
the relationship between gestational age
TABLE 1
Final metabolite model in the model-building dataset (n[ 153,342) for prediction of gestational age
Metabolite
Metabolite Metabolite Squared Metabolite Cubed
Coefficient SE Coefficient SE Coefficient SE
TSH 0.01 8.810-4 8.810-5 1.210-5 1.310-7 2.310-8
17-OHP 0.05 5.210-4 1.110-4 3.510-6 N/A N/A
GALT 0.07 0.01 3.510-3 7.510-4 N/A N/A
ALA 9.610-3 2.710-4 1.310-5 6.310-7 5.310-9 3.710-10
ARG 0.02 1.510-3 2.910-5a 1.010-5 N/A N/A
LEU 0.01 3.310-4 1.710-5 8.310-7 4.310-9 2.110-10
MET 0.03 1.210-3 2.310-4 1.210-5 3.510-7 1.810-8
PHE 0.01 8.310-4 4.210-5 4.710-6 2.910-8 3.910-9
TYR 5.310-3 1.210-4 N/A N/A N/A N/A
VAL 0.02 6.010-4 3.610-5 2.510-6 2.010-8 1.010-9
C2 0.10 4.410-3 2.010-3 1.110-4 1.210-5 8.510-7
C3 0.06 5.610-3 N/A N/A N/A N/A
C4 0.20 0.03 N/A N/A N/A N/A
C5 9.29 0.26 6.93 0.78 6.81 0.43
C5:1 3.89 0.56 N/A N/A N/A N/A
C5-OH 0.36 0.08 N/A N/A N/A N/A
C3-DC 0.91 0.10 N/A N/A N/A N/A
C4-DC 18.56 0.41 50.43 1.67 40.19 1.92
C5-DC 25.06 0.92 85.79 8.60 118.09 23.90
C6 10.16 0.31 2.24 0.42 N/A N/A
C8 1.47 0.20 0.11 0.02 2.010-3 3.010-4
C8:1 13.29 0.50 52.96 2.51 55.61 3.64
C10 4.99 0.32 10.87 0.91 3.97 0.52
C10:1 2.33 0.27 N/A N/A N/A N/A
C12 2.47 0.19 4.00 0.37 2.10 0.22
C12:1 5.17 0.30 13.00 0.85 9.71 0.72
C6-DC 4.20 0.36 9.65 2.13 N/A N/A
C14 3.03 0.32 1.94 0.48 N/A N/A
C16 2.99 0.07 0.58 0.02 0.04 1.510-3
C16:1 9.73 0.55 18.06 1.63 10.40 1.59
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ajog.org OBSTETRICS Original Researchand age at time of screening as well as
gestational age with weight. To address
nonlinearity between age and weight
with gestational age, squared terms and
then the cubed terms were included for
each model.
We performed a sensitivity analysis
excluding newborns identiﬁed as
potentially affected with an endocrine
disorder or inborn error of metabolism,ie, one or more metabolite levels excee-
ded the threshold considered within the
normal range for a healthy newborn.
Statistical outliers also were evaluated
with studentized residuals by excluding
those observations with residuals less
than 1.96 and greater than 1.96. The
coefﬁcient of determination (R2) and the
root-mean-square error (RMSE) are
presented for each regression model. AllAPRIL 2016 Amerianalyses were performed in STATA
version 12.0 (College Station, TX).
The ﬁnal model was used to predict
gestational age in the model-testing
dataset (n ¼ 76,671). The coefﬁcient of
determination (R2) and the RMSE are
presented for the entire model-testing
dataset as well as stratiﬁed by sex and
weight for gestational age. Sensitivity
and speciﬁcity were calculated bycan Journal of Obstetrics& Gynecology 515.e3
TABLE 1
Final metabolite model in the model-building dataset (n[ 153,342) for prediction of gestational age (continued)
Metabolite
Metabolite Metabolite Squared Metabolite Cubed
Coefficient SE Coefficient SE Coefficient SE
C18 7.96 0.23 4.96 0.20 1.02 0.05
C18:1 4.09 0.18 1.70 0.11 0.24 0.02
C18:2 4.22 0.19 3.01 0.35 1.22 0.17
C14-OH 27.02 1.83 287.34 35.03 N/A N/A
C16-OH 10.91 2.58 239.18 62.78 1585.56a 460.58
C16:1-OH 7.32 1.09 18.72b 8.87 N/A N/A
C18:1-OH 3.84 0.82 N/A N/A N/A N/A
Constant 36.72 0.11 N/A N/A N/A N/A
GALT, galactose-1-phosphate uridyl transferase; N/A, not available; 17-OHP, 17-hydroxyprogesterone TSH, thyroid-stimulating hormone.
All terms are significant at P < .001 unless otherwise noted.
a P<.01; b .01P<.05.
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prediction of preterm birth less than
<37 weeks’ gestation compared with
term birth (37 weeks). Because birth-
weight can also predict gestational age,
we evaluated the sensitivity and speci-
ﬁcity with each preterm birth outcome
in a model that included only infant
weight and its squared and cubed terms.
Next, we evaluated the sensitivity and
speciﬁcity of each preterm birth
outcome using a model that contained
the ﬁnal set of metabolites plus weight
and their subsequent squared and cubed
terms to examine the extent to which
adding weight improves prediction over
that based on the metabolites alone.
Results
General characteristics of the
population and the newborn
metabolic model
Gestational age distributions were com-
parable in both the model-building and
model-testing datasets, with 8.9% of the
total population being born preterm
(<37 weeks) (Supplementary Table 2).
Distributions of neonatal weight, small-
and large-for-gestational age, sex, total
parenteral nutrition, and age at time of
screening were similar in both the
model-building and model-testing
datasets (Supplementary Table 2). All
univariate analyses between each515.e4 American Journal of Obstetrics& Gynecolmetabolite (including the squared and
cubed terms) with gestational age were
signiﬁcant at P < .01 (data not shown).
Within the model-building dataset, the
full model including 1 categorical vari-
able (biotinidase), 43 continuous
metabolite measurements, and their
squared and cubed terms produced
comparable performance statistics (R2¼
53.2%, RMSE ¼ 1.3) to the metabolic
model including only signiﬁcant terms
(R2 ¼ 53.1%, RMSE ¼ 1.3). Therefore,
our ﬁnal newborn metabolic linear
regression model consisted of 88 pa-
rameters, including the intercept, 37
metabolite measures, 29 squared
metabolite measures, and 21 cubed
metabolite measures (Table 1). Metabo-
lites in the ﬁnalmodel included TSH, 17-
OHP, galactose-1-phosphate uridyl
transferase, 7 amino acids, and 27
acylcarnitines.
Model performance in model-
building dataset
The newborn metabolic model
explained 53.1% of the variation in
gestational age in the model-building
dataset. The average difference between
gestational ages predicted by the
newborn metabolic model and the
recorded gestational age was 1.3 weeks
(Table 2). The prediction of gestational
age by the use of the newborn metabolicogy APRIL 2016model was robust to inclusion of cova-
riates. Speciﬁcally, including month and
year of sample collection, multiple ges-
tations, infant age at time of sample
collection in hours, infant sex, and
weight for gestational age did not
improve the prediction of gestational
age. Each of these covariates alone,
explained very little of the variation in
gestational age (R2 < 5%; RMSEw 1.9
weeks). Sensitivity analyses demonstrate
that gestational age estimated by the
newborn metabolic model was not
impacted by exclusion of newborns with
potential endocrine disorders or inborn
errors of metabolism, newborns
receiving total parenteral nutrition or
multiple gestations (Table 2). The
removal of statistical outliers unsurpris-
ingly improved model performance
(R2¼ 55.4; RMSE¼ 1.1); however, there
was no reason to suspect that the
metabolite values of these individuals
were not true values and we chose not to
remove these individuals from further
analyses.
Comparison of the newborn
metabolic model to including only
neonatal weight in the model-
building dataset
In the model-building dataset, neonatal
weight alone explained 54.5% of the
variation in gestational age. The average
TABLE 2
Percent of variation in gestational age explained by neonatal metabolic screening markers in the model-building
dataset
Model description No. model parametersa No. observations R2 (%) RMSE
Final metabolite model 88 153,342 53.1 1.3
Final metabolite model excluding infants with abnormal neonatal screens 88 148,104 50.1 1.3
Final metabolite model excluding infants on total parenteral nutrition 88 151,293 47.9 1.3
Final metabolite model excluding statistical outliers as defined as those
with residuals less than 1.96 and greater than 1.96
88 146,083 55.4 1.1
Final metabolite model þ month and year of collection 104 153,342 53.4 1.3
Month and year of collection only 17 153,342 1.2 1.9
Final metabolite model þ multiple gestation status (yes/no) 89 153,342 53.7 1.3
Multiple gestation status only 2 153,342 4.8 1.9
Final metabolite model including only singleton births 88 147,597 49.4 1.3
Final metabolite model þ age at collection (hours) 91 153,322 53.1 1.3
Age at collection (hours) only 4 153,322 0.05 1.9
Final metabolite model in subset with nonmissing age at collection 88 153,322 53.1 1.3
Final metabolite model þ infant sex 89 152,674 53.2 1.3
Infant sex only 2 152,674 0.02 1.9
Final metabolite model in subset with non-missing infant sex 88 152,674 53.1 1.3
Final metabolite model þ infant weight, g 91 153,008 66.1 1.1
Infant weight, g only 4 153,008 54.5 1.3
Final metabolite modelþ weight for gestational age (AGA, LGA, and SGA) 90 153,008 53.1 1.3
Weight for gestational age (AGA, LGA, and SGA) only 3 153,008 0 1.9
Final metabolite model in subset with nonmissing weight 88 153,008 52.9 1.3
AGA, average-for-gestational age; LGA, large-for-gestational age; RMSE, root-mean-square error; SGA, small-for-gestational age.
a Model parameters include the intercept term.
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ajog.org OBSTETRICS Original Researchdifference between gestational ages pre-
dicted by neonatal weight alone and the
recorded gestational age was 1.3 weeks
(Table 2). Including neonatal weight in
the newborn metabolic model improved
the difference between the predicted
gestational ages and recorded gestational
age by 0.2 weeks and explained 66.1% of
the variation in gestational age. Inclusion
of neonatal metabolite measurements
explained an additional 12% of the
variation in gestational age above and
beyond neonatal weight (Table 2).
Performance of the newborn
metabolic model in the model-
testing dataset
In the model-testing dataset, the
newborn metabolic model estimatedgestational age within 1 week for 78% of
the individuals and within 2 weeks of
gestation for 95% of the individuals. One
individual had a predicted gestational
age of 172 weeks, which was likely
attributable to the fact that this individ-
ual had multiple abnormal metabolite
levels. We excluded this individual from
subsequent evaluation of model perfor-
mance. In the model-testing dataset, the
newborn metabolic model (n ¼ 76,670)
predicted 52.8% of the variation in
gestational age. The average difference
between the gestational ages predicted by
the newborn metabolic model and the
recorded gestational age was 1.3 weeks,
which was comparable (R2 ¼ 52.8%,
RMSE¼ 1.3) to the model including the
excluded individual (n ¼ 76,671).APRIL 2016 AmeriComparison of the newborn
metabolic model to including only
neonatal weight in the model-
testing dataset
In the model-testing dataset neonatal
weight alone explained 54.6% of the
variation in gestational age. The average
difference between gestational ages pre-
dicted by neonatal weight alone and the
recorded gestational age was 1.3 weeks.
Similar to the ﬁndings in the model-
building dataset, including neonatal
weight in the newborn metabolic model
improved the difference between the
predicted gestational ages and recorded
gestational age by 0.2 weeks in the
model-testing dataset. The model
including neonatal weight with the
newborn metabolic model explainedcan Journal of Obstetrics& Gynecology 515.e5
FIGURE
Receiver operator curves of
metabolic and weight models for
identifying those born preterm
(<37 completed weeks) vs those
born term (‡37 completed weeks)
Curves for weight at collection only model (solid
line), metabolic final model (dashed line), and
weight plus metabolic model (dotted line).
Ryckman. Metabolic predictors of gestational age. Am J
Obstet Gynecol 2016.
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in the model-testing dataset. Therefore,
inclusion of neonatal metabolite mea-
surements explained an additional 12%
of the variation in gestational age above
and beyond neonatal weight.
The overall estimated prevalence of
preterm birth (5.0%) when we used the
newborn metabolic model was slightly
closer to the percentage of preterm birth
(8.9%) estimated with the recorded
gestational age than the model including
only neonatal weight (4.7%). The
newborn metabolic model yielded anTABLE 3
Prevalence of gestational age groups i
Gestational age
Actual gestational age
n %
32 1177 1.54
3334 1271 1.66
3536 4364 5.69
3738 18,927 24.69
3940 44,151 57.59
>40 6781 8.84
Missing 0.00 0.00
Ryckman. Metabolic predictors of gestational age. Am J Obs
515.e6 American Journal of Obstetrics& Gynecolarea under the curve (AUC) of 0.899
(95% conﬁdence interval [95% CI]
0.8950.903) in differentiating those
born preterm (<37 weeks) from those
born term (37 weeks) (Figure and
Supplementary Table 3). The newborn
metabolic model offers slight improve-
ment in identifying those born preterm
(<37 weeks) over the model including
only neonatal weight (AUC 0.881, 95%
CI 0.8760.886). Including neonatal
weight in the newborn metabolic model
provides the best estimation of gesta-
tional age with an AUC of 0.938 (95% CI
0.9340.941).
Performance of the newborn
metabolic model in neonates born
very preterm or small-for-
gestational age
The newborn metabolic model under-
estimated very preterm birth (<32
weeks) compared with the model
including only neonatal weight
(Table 3). There was no increased ability
to discriminate between very preterm
birth (<32 weeks) and all other births
(32 weeks) using the newborn meta-
bolic model over the model including
only neonatal weight (Table 3 and
Supplementary Figure).
The most evident difference in model
performance was in small- and large-for-
gestational age neonates. The average
difference between gestational ages pre-
dicted by the newborn metabolic model
and the reported gestational age was 1.5
weeks compared with the model withn the model-testing dataset, n[ 76,671
Metabolic model
Cum% n % Cum
0.00 674 0.88 0
3.19 876 1.14 2
8.88 2291 2.99 5
33.57 20,994 27.38 32
89.62 50,600 66.00 97
100.00 1235 1.61 99
100.00 1 0.00 100
tet Gynecol 2016.
ogy APRIL 2016only neonatal weight (RMSE ¼ 1.9
weeks). In large-for-gestational age ne-
onates, the average difference between
gestational ages predicted by the
newborn metabolic model and the re-
ported gestational age was 1.4 weeks, an
improvement over the model with only
neonatal weight (RMSE ¼ 1.8 weeks).
Improvement over the model
including only neonatal weight also was
observed when we examined the pre-
dicted prevalence of preterm birth in the
subset of small-for-gestational age neo-
nates (Table 4). The model including
only neonatal weight overestimated the
prevalence of very preterm birth (<32
weeks) by over twice that of the actual
prevalence (3.45% vs 1.61%, respec-
tively), whereas the newborn metabolic
model only marginally underestimated
the prevalence of very preterm birth
compared with the actual prevalence
(1.00% vs 1.61%, respectively). For
preterm birth <37 weeks’ gestation, the
model including only neonatal weight
estimated the prevalence at 18.79% in
small-for-gestational age neonates, over
twice that of the actual prevalence of
9.20%. Again the newborn metabolic
model underestimated preterm birth but
was closer to the true prevalence at
6.94% than the models including only
neonatal weight (Table 4).
Comment
Primary findings of the study
Our primary ﬁndings were as follows:
(1) The newborn metabolic proﬁle, asWeight-only model
% n % Cum%
.00 891 1.16 0.00
.02 604 0.79 1.95
.01 2089 2.72 4.67
.39 15,306 19.96 24.64
.51 57,613 75.14 98.62
.99 0 0.00 99.78
.00 168 0.22 100.00
TABLE 4
Prevalence of gestational age groups in the model-testing dataset for small-for-gestational age neonates, n[ 7502
Gestational age
Actual gestational age Metabolic model Weight-only model
n % Cum% n % Cum% n % Cum%
32 121 1.61 1.61 75 1.00 1.00 259 3.45 3.45
3334 132 1.76 3.37 122 1.63 2.63 199 2.65 6.11
3536 437 5.83 9.20 324 4.32 6.94 952 12.69 18.79
3738 1831 24.41 33.60 2421 32.27 39.22 5861 78.13 96.92
3940 4304 57.37 90.98 4481 59.73 98.95 231 3.08 100.00
>40 677 9.02 100.00 79 1.05 100.00 0 0.00 100.00
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can accurately predict gestational age to
the same degree and slightly better than
neonatal weight alone; (2) the newborn
metabolic model predicts gestational
age to a better degree than neonatal
weight alone in small and large for
gestational age neonates; (3) newborn
screening measurements can be used for
population surveillance of preterm birth
rates in the absence of prenatal ultra-
sound measurements; and (4) models
including both the metabolites and
neonatal weight provide the best pre-
diction of gestational age.
Significance of gestational age
estimation at birth
Medical care and treatment of preterm
neonates is of critical public health
importance. Globally, approximately
15 million babies are born preterm (<37
weeks’ gestation) and 1.1 million deaths
are attributable to preterm birth.11,21
Preterm birth remains one of the single
greatest contributors to infant mortality
in the United States22 and to disability-
adjusted life years worldwide.23
Approximately, 60% of all preterm
births occur in low-resource settings,
including Africa and South Asia.11 Ac-
curate gestational age estimation is not
only important for clinical decisions
regarding the management and treat-
ment of speciﬁc pregnancies but also for
identifying areas with particularly high
rates of preterm birth. We present a
novel method for estimating gestational
age based on the metabolic proﬁle of thenewborn that offers improvement over
prediction using neonatal weight alone.
Newborn metabolic profiles,
gestational age, and fetal growth
Previous studies by our group have
identiﬁed TSH, 17-OHP, amino acids,
and acylcarnitines as potentially impor-
tant markers of gestational age.18 Other
studies have shown similar results in
maternal blood, cord blood, and
neonatal urine.13-16 Differences in these
metabolites by gestational age often are
attributed to fetal sickness, stress, and
immaturity of kidney, adrenal gland, and
liver function. Additionally, because of
their unique anatomy (large surface to
volume ratio and large head to body
ratio) and physiology (hepatic immatu-
rity), premature neonates often have
disrupted glucose homeostasis and may
require glucose infusion early in life to
prevent hypoglycemia.24 A disruption
in glucose homeostasis can lead to an
increase in amino acids and acylcarni-
tines that are important intermediates in
beta oxidation and the Kreb’s cycle such
as the metabolites measured as part of
newborn screening.
Neonatal metabolism, as represented
by newborn screening measurements, is
a function of not only gestational age but
growth in utero.25,26 This point is further
supported by the ability of the metabo-
lite markers to predict 37.3% of the
variation in weight in the model-testing
dataset. Additionally, the newborn
metabolic model outperforms neonatal
weight alone in predicting gestationalAPRIL 2016 Ameriage, particularly in small-for-gestational
age neonates.
Clinical significance of gestational
age dating at birth
Neonatal metabolism is a function of not
only in utero growth but also maternal
metabolism reﬂected by the transfer of
nutrients from the mother to the child
via the placenta.25 Therefore, studies
examining these speciﬁc biomarkers
throughout pregnancy could provide in-
sights into preterm birth etiology as well
as better methods of gestational age
dating, particularly in small or large for
gestational fetuses. Determining gesta-
tional age postbirth is important for
differentiating neonates who are preterm
from those who are small-for-gestational
age. The distinction between infants
born preterm and average-for-gestational
age, infants born preterm and small-for-
gestational age, and term infants born
small-for-gestational age is important
because themorbidity andmortality risks
differ between these groups.2731 Meta-
bolic proﬁling at birth is unlikely to pro-
vide immediate information for clinical
decision making; however, for long-term
follow-up, it may be important to
distinguish accurately between the small-
for-gestational age infant and the pre-
term, average-for-gestational age infant.
Newborn metabolic profiles and
accurate estimation of preterm
birth rates
Reporting of gestational age on the US
Standard Certiﬁcate of Live Birth hascan Journal of Obstetrics& Gynecology 515.e7
Original Research OBSTETRICS ajog.orgbeen based primarily on last menstrual
period and often is used to report na-
tional rates of preterm birth.32 In 2014,
however, the obstetric estimate will
replace last menstrual period as the pri-
mary standard for reporting gestational
age.32 The obstetric estimate is deﬁned as
the best estimate of the infant’s gestation
in completed weeks and is based on all
available information, including last
menstrual period and fetal ultrasound
measurements. Comparisons in report-
ing methods demonstrate a 2% reduc-
tion in the preterm birth rate when
obstetric estimate is reported instead of
last menstrual period.32 When the
newborn metabolic model was used, our
estimated preterm birth rate was about
3% less than the rate calculated based on
the recorded gestational age, which was
based on a mixture of gestational ages
solely reported by last menstrual period
and some reported by obstetric estimate.
Further studies are needed that directly
compare the metabolic model to the
gestational age obtained by early ultra-
sound dating to accurately assess the
validity of this method in estimating
preterm birth.
Newborn metabolic profiles and
global surveillance of preterm birth
Global surveillance of preterm birth is
important for improving intervention
programs by targeting them to areas with
the greatest rates of preterm birth. Our
method of gestational age prediction
based on newborn screening metabolites
provides several important insights and
implications for preterm birth surveil-
lance. Estimating gestational age in low-
resource areas is hampered by lack of
prenatal care services and ultrasound
dating.11 Measuring these metabolites
from a dried blood spot specimen offers
several advantages beyond gestational
age dating alone. Newborn metabolic
screening using tandem mass spec-
trometry has long been recognized as a
critical public health initiative to identify
often rare conditions that if detected
early enough can be treated to avoid
serious morbidity or death.19 Although
in low-resource settings it is unlikely that
the infrastructure could be easily estab-
lished to ensure timely detection and515.e8 American Journal of Obstetrics& Gynecoltreatment of these conditions, data are
severely lacking on the incidence of these
conditions in regions of the world
including Sub-Saharan Africa.33 Under-
standing the incidence of these condi-
tions around the world would aid in
developing targeted screening tests that
may be more readily incorporated in
low-resource settings than tandem mass
spectrometry.
Strengths and limitations of our
study
Our study was strengthened by the large
sample size and the ability to validate
our model in a subset of the data.
Although our method generalizes to the
population of Iowa, which is primarily
white, validating in other populations,
including low-resource countries such as
Africa will be important. Our analysis of
newborn screening records was retro-
spective and did not include evaluation
of the birth certiﬁcate or medical record;
therefore, we are limited to the gesta-
tional age and selected characteristics
provided to the newborn screening
program, such as weight, sex, and age at
time of newborn screening. In addition,
the gestational age was provided by the
health care provider, and it was un-
known whether this was based on last
menstrual period, fetal ultrasound, or a
combination of both. Previously, how-
ever, we have examined newborn
screening data linked to medical record
data for 523 preterm newborns34,35 and
found that gestational age by best ob-
stetric estimate was highly correlated
with the gestational age reported on the
newborn screening card (rho¼0.988)
(data not shown). In fact, 98% of the
records matched within 1 gestational age
week to the best obstetric estimate (ie,
prenatal ultrasound or last menstrual
period in the absence of prenatal ultra-
sound) with 86% being an exact match.
Similar concordance was true for weight
at time of newborn screening, which was
strongly correlated (rho¼0.990) to
birthweight. Approximately, 99% of
newborn screening records reported
weight within 500 g (w1 pound) of the
birthweight and 86% were within 100 g
(w0.2 pounds) of birthweight. In addi-
tion, we were limited to the metabolitesogy APRIL 2016provided on the newborn screening
panel. There are additionalmeasures such
as glucose and T-cell receptor excision
circle analysis that are currently being
added to routine screening panels across
the United States and are also shown to
correlate strongly with gestational age.36
Conclusion
Our novel method of estimating
gestational age at birth using the
newbornmetabolic proﬁle, derived from
markers routinely captured by newborn
screening, provides more information
than neonatal weight alone, particularly
in small-for-gestational age infants. Our
method, however, still underestimates
preterm birth prevalence, particularly
very preterm birth. Therefore, it is
important to examine the utility of our
model with other methods of gestational
age estimation at birth including Ballard
and Dubowitz scoring systems as well as
emerging technologies such as retinal
and lens vessel scans. Establishing
methods of gestational age dating at
birth using metabolic proﬁling could
also have substantial beneﬁts for
improving infant and child health that
extend beyond the estimation of gesta-
tional age alone. n
Acknowledgments
We express our thanks to the Congenital and
Inherited Disorders Advisory Committee,
particularly Kimberly Noble Piper at the Iowa
Department of Public Health for her enthusiastic
support andmanagement. Wewould also like to
express our gratitude to the State Hygienic
Laboratory staff, including a special thanks to
Dari Shirazi and Frank Delin. We thank Dr.
George Wehby, Associate Professor in the
Department of Health Management and Policy,
at the University of Iowa for contributing sub-
stantially to the conceptual framework and the
designing of the analysis plan.
References
1. Lawn JE, Kinney M. Preterm birth: now the
leading cause of child death worldwide. Sci
Transl Med 2014;6:263ed221.
2. Tunon K, Eik-Nes SH, Grottum P.
A comparison between ultrasound and a reliable
last menstrual period as predictors of the day of
delivery in 15,000 examinations. Ultrasound
Obstet Gynecol 1996;8:178-85.
3. Kieler H, Axelsson O, Nilsson S,
Waldenstrom U. Comparison of ultrasonic
measurement of biparietal diameter and last
menstrual period as a predictor of day of delivery
ajog.org OBSTETRICS Original Researchin women with regular 28 day-cycles. Acta
Obstet Gynecol Scand 1993;72:347-9.
4. LynchCD, Zhang J. The research implications
of the selection of a gestational age estima-
tion method. Paediatr Perinatal Epidemiol
2007;21(Suppl 2):86-96.
5. Hadlock FP, Deter RL, Harrist RB, Park SK.
Estimating fetal age: computer-assisted analysis
of multiple fetal growth parameters. Radiology
1984;152:497-501.
6. Chervenak FA, Skupski DW, Romero R, et al.
How accurate is fetal biometry in the assess-
ment of fetal age? Am J Obstet Gynecol
1998;178:678-87.
7. Dubowitz LM, Dubowitz V, Goldberg C.
Clinical assessment of gestational age in the
newborn infant. J Pediatr 1970;77:1-10.
8. Ballard JL, Khoury JC, Wedig K, Wang L,
Eilers-Walsman BL, Lipp R. New Ballard Score,
expanded to include extremely premature in-
fants. J Pediatr 1991;119:417-23.
9. Sanders M, Allen M, Alexander GR, et al.
Gestational age assessment in preterm neo-
nates weighing less than 1500 grams. Pediatrics
1991;88:542-6.
10. Alexander GR, de Caunes F, Hulsey TC,
Tompkins ME, Allen M. Validity of postnatal as-
sessments of gestational age: a comparison of
the method of Ballard et al. and early ultraso-
nography. Am J Obstet Gynecol 1992;166:
891-5.
11. BlencoweH, Cousens S, Chou D, et al. Born
too soon: the global epidemiology of 15 million
preterm births. Reprod Health 2013;10(Suppl
1):S2.
12. Blair E, Liu Y, CosgroveP.Choosing the best
estimate of gestational age from routinely
collected population-based perinatal data. Pae-
diatr Perinatal Epidemiol 2004;18:270-6.
13. Horgan RP, Broadhurst DI, Walsh SK, et al.
Metabolic proﬁling uncovers a phenotypic
signature of small for gestational age in
early pregnancy. J Proteome Res 2011;10:
3660-73.
14. Heazell AE, Bernatavicius G, Warrander L,
BrownMC, DunnWB. Ametabolomic approach
identiﬁes differences in maternal serum in third
trimester pregnancies that end in poor perinatal
outcome. Reprod Sci 2012;19:863-75.
15. Alexandre-Gouabau MC, Courant F,
Moyon T, et al. Maternal and cord blood LC-
HRMS metabolomics reveal alterations in
energy and polyamine metabolism, and oxida-
tive stress in very-low birth weight infants.
J Proteome Res 2013;12:2764-78.
16. Atzori L, Antonucci R, Barberini L, et al. 1H
NMR-based metabolomic analysis of urine frompreterm and term neonates. Front Biosci (Elite
Ed) 2011;3:1005-12.
17. Clark RH, Kelleher AS, Chace DH,
Spitzer AR. Gestational age and age at sampling
inﬂuence metabolic proﬁles in premature infants.
Pediatrics 2014;134:e37-46.
18. Ryckman KK, Berberich SL,
Shchelochkov OA, Cook DE, Murray JC. Clinical
and environmental inﬂuences on metabolic bio-
markers collected for newborn screening. Clin
Biochem 2013;46:133-8.
19. Bennett MJ. Newborn screening for meta-
bolic diseases: saving children’s lives and
improving outcomes. Clin Biochem 2014;47:
693-4.
20. Clinical Laboratory Standards Institute.
Blood Collection on Filter Paper for Newborn
Screening Programs; Approved Standard-Sixth
Edition. CLSI document NBS01-A6. Wayne,
PA: Clinical Laboratory Standards Institute;
2013.
21. Liu L, Johnson HL, Cousens S, et al. Global,
regional, and national causes of child mortality:
an updated systematic analysis for 2010 with
time trends since 2000. Lancet 2012;379:
2151-61.
22. Callaghan WM, MacDorman MF,
Rasmussen SA, Qin C, Lackritz EM. The
contribution of preterm birth to infant mortality
rates in the United States. Pediatrics 2006;118:
1566-73.
23. Ezzati M, Lopez AD, Rodgers A, Vander
Hoorn S, Murray CJ. Comparative Risk
Assessment Collaborating Group. Selected
major risk factors and global and regional
burden of disease. Lancet 2002;360:1347-60.
24. Mitanchez D. Glucose regulation in preterm
newborn infants. Hormone Res 2007;68:
265-71.
25.Wu G, Imhoff-Kunsch B, Girard AW.
Biological mechanisms for nutritional regula-
tion of maternal health and fetal development.
Paediatr Perinat Epidemiol 2012;26(Suppl 1):
4-26.
26. Moltu SJ, Sachse D, Blakstad EW, et al.
Urinary metabolite proﬁles in premature in-
fants show early postnatal metabolic adap-
tation and maturation. Nutrients 2014;6:
1913-30.
27. Kc A, Wrammert J, Nelin V, Ewald U,
Clark R, Malqvist M. Level of mortality risk for
babies born preterm or with a small weight for
gestation in a tertiary hospital of Nepal. BMC
Public Health 2015;15:877.
28. Vrachnis N, Botsis D, Iliodromiti Z. The fetus
that is small for gestational age. Ann N Y Acad
Sci 2006;1092:304-9.APRIL 2016 Ameri29. Tyson JE, Kennedy K, Broyles S,
Rosenfeld CR. The small for gestational age
infant: accelerated or delayed pulmonary
maturation? Increased or decreased survival?
Pediatrics 1995;95:534-8.
30. Giapros V, Drougia A, Krallis N,
Theocharis P, Andronikou S. Morbidity and
mortality patterns in small-for-gestational age
infants born preterm. J Matern Fetal Neonatal
Med 2012;25:153-7.
31. McIntire DD, Bloom SL, Casey BM,
Leveno KJ. Birth weight in relation to morbidity
and mortality among newborn infants. N Engl J
Med 1999;340:1234-8.
32. Martin JA, Osterman MJ, Kirmeyer SE,
Gregory EC. Measuring gestational age
in vital statistics data: transitioning to the ob-
stetric estimate. Natl Vital Stat Rep 2015;64:
1-20.
33. Therrell BL, Padilla CD, Loeber JG, et al.
Current status of newborn screening worldwide:
2015. Semin Perinatol 2015;39:171-87.
34. Ryckman KK, Dagle JM, Shchelochkov OA,
et al. Association of amino acids with common
complications of prematurity. Pediatr Res
2013;73:700-5.
35. Ryckman KK, Spracklen CN, Dagle JM,
Murray JC. Maternal factors and complications
of preterm birth associated with neonatal thyroid
stimulating hormone. J Pediatr Endocrinol
Metab 2014;27:929-38.
36. Kwan A, Puck JM. History and current sta-
tus of newborn screening for severe combined
immunodeﬁciency. Semin Perinatol 2015;39:
194-205.
Author and article information
From the Departments of Epidemiology (Dr Ryckman),
and Pediatrics (Drs Ryckman and Dagle), University of
Iowa, Iowa City, IA; and the State Hygienic Laboratory at
the University of Iowa (Dr Baerberich), Coralville, IA.
Received Aug. 22, 2015; revised Nov. 2, 2015;
accepted Nov. 23, 2015.
The authors report no conflict of interest.
This research is supported, in part, by the Eunice
Kennedy Shriver National Institute of Child Health and
Human Development (R00 HD-065786). The content is
solely the responsibility of the authors and does not
necessarily represent the official views of the Eunice
Kennedy Shriver National Institute of Child Health and
Human Development or the National Institutes of Health.
This work was also supported by the Bill and Melinda
Gates Foundation Grand Challenges Explorations grant,
round 13.
Corresponding author: Kelli K. Ryckman, PhD.
kelli-ryckman@uiowa.educan Journal of Obstetrics& Gynecology 515.e9
SUPPLEMENTARY FIGURE
Receiver operator curves of
metabolic and weight models for
identifying those born preterm
(<32 completed weeks) vs all
others (‡32 completed weeks)
Curves for weight at collection only model (solid
line), metabolic final model (dashed line), and
weight plus metabolic model (dotted line).
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SUPPLEMENTARY TABLE 1
Enzymes and metabolites evaluated on every infant born between 2004 and 2009 by the Iowa Neonatal
Screening Program
Enzymes and Hormones Acylcarnitines (mmol/L)
17-Hydroxyprogesterone (17OHP - ng/mL) Glutarylcarnitine (C5-DC)
Biotinidase (BIO e 3þ, 2þ and 1þ/0) 3-Hydroxyisovalerylcarnitine (C5-OH)
Galactose-1-Phosphate Uridyl Transferase (GALT - U/gHb) Hexanoylcarnitine (C6)
Thyroid-stimulating hormone (TSH - mIU/L) Methylglutarylcarnitine (C6-DC)
Amino acids (mmol/L) Octanoylcarnitine (C8)
Alanine (ALA) Octenoylcarnitine (C8:1)
Arginine (ARG) Decanoylcarnitine (C10)
Citrulline (CIT) Decenoylcarnitine (C10:1)
Glutamate (GLU) Dodecanoylcarnitine (C12)
IsoleucineþLeucine (LEU) Dodecenoylcarnitine (C12:1)
Methionine (MET) Tetradecanoylcarnitine (C14)
Phenylalanine (PHE) Tetradecenoylcarnitine (C14:1)
Tyrosine (TYR) Tetradecadienoylcarnitine (C14:2)
Valine (VAL) 3-Hydroxytetradecanoylcarnitine (C14-OH)
Acylcarnitines (umol/L) Palmitoylcarnitine (C16)
Carnitine free (C0) Palmitoleylcarnitine (C16:1)
Acetylcarnitine (C2) 3-Hydroxypalmitoleylcarnitine (C16:1-OH)
Propionylcarnitine (C3) 3-Hydroxypalmitoylcarnitine (C16-OH)
Malonylcarnitine (C3-DC) Stearoylcarnitine (C18)
ButyrylcarnitineþIsobutyrylcarnitine (C4) Oleoylcarnitine (C18:1)
Methylmalonylcarnitine (C4-DC) 3-Hydroxyoleoylcarnitine (C18:1-OH)
IsovalerylcarnitineþMethylbutyrylcarnitine (C5) Linoleoylcarnitine (C18:2)
Tiglylcarnitine (C5:1) 3-Hydroxystearoylcarnitine (C18-OH)
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SUPPLEMENTARY TABLE 2
Characteristics of Iowa Neonatal Metabolic Screening Data, 2004L2009
Variable
Model-building
n ¼ 153,342
Model-testing
n ¼ 76,671
Entire cohort
n ¼ 230,013
n % n % n %
Gestational age, completed wk
20e31 1754 1.1 866 1.1 2620 1.1
32e36 12,218 8.0 5946 7.8 18,164 7.9
37e40 126,042 82.2 63,078 82.3 189,120 82.2
41e45 13,328 8.7 6781 8.8 20,109 8.7
Birth weight, g
451e1499 1604 1.1 844 1.1 2448 1.1
1500e2499 10,036 6.5 4822 6.3 14,858 6.5
2500e3999 130,652 85.2 65,551 85.5 196,203 85.3
4000e5000 11,020 7.2 5437 7.1 16,457 7.2
Unknown 30 0.02 17 0.02 47 0.02
Weight for gestational age
SGA 15,278 10.0 7502 9.8 22,780 9.9
AGA 122,477 79.9 61,412 80.1 183,889 80.0
LGA 15,253 10.0 7589 9.9 22,842 9.9
Unknown 334 0.2 168 0.2 502 0.2
Age at time of screening, h
0e24 21,862 14.3 10,887 14.2 32,749 14.2
25e72 128,053 83.5 64,124 83.6 192,177 83.6
>72 3407 2.2 1649 2.2 5056 2.2
Unknown 20 0.01 11 0.01 31 0.01
Sex
Male 78,121 51.1 39,230 51.2 117,351 51.0
Female 74,553 48.6 37,135 48.4 111,688 48.6
Unknown 668 0.4 306 0.4 974 0.4
Total parenteral nutrition
Y 2049 1.3 1029 1.3 3078 1.3
N 151,293 98.7 75,642 98.7 226,935 98.7
Ryckman. Metabolic predictors of gestational age. Am J Obstet Gynecol 2016.
Original Research OBSTETRICS ajog.org
515.e12 American Journal of Obstetrics& Gynecology APRIL 2016
SUPPLEMENTARY TABLE 3
Sensitivity and specificity of metabolic models with andwithout weight for identifying those born preterm (<37weeks)
vs those born term (‡37 weeks) in the model-testing dataset
Preterm
definition
Weight-only model
AUC 0.8809 (95% CI 0.87620.8856)
Metabolic model
AUC 0.8988 (95% CI 0.89470.9030)
Weight þ metabolic model
AUC 0.9376 (95% CI 0.93440.9407)
Sensitivity Specificity Classified Sensitivity Specificity Classified Sensitivity Specificity Classified
<41 100.00% 0.00% 8.88% 99.96% 1.76% 10.49% 99.99% 0.88% 9.68%
<40 98.53% 19.49% 26.51% 98.56% 26.38% 32.79% 99.34% 28.17% 34.49%
<39 83.62% 81.05% 81.28% 89.94% 73.22% 74.71% 93.89% 77.74% 79.17%
<38 61.61% 95.81% 92.77% 66.87% 94.54% 92.09% 76.27% 95.27% 93.58%
<37 42.16% 98.97% 93.92% 45.24% 98.91% 94.15% 54.29% 99.12% 95.14%
<36 29.00% 99.70% 93.42% 30.92% 99.73% 93.61% 36.82% 99.80% 94.21%
<35 20.89% 99.89% 92.88% 21.81% 99.91% 92.97% 26.53% 99.91% 93.40%
<34 16.10% 99.92% 92.48% 14.74% 99.96% 92.39% 18.81% 99.95% 92.75%
<33 12.54% 99.94% 92.18% 9.70% 99.98% 91.96% 14.32% 99.97% 92.36%
<32 10.00% 99.95% 91.97% 6.59% 99.99% 91.69% 11.07% 99.98% 92.08%
<31 7.89% 99.97% 91.79% 4.42% 99.99% 91.50% 8.77% 99.99% 91.89%
<30 6.12% 99.98% 91.64% 2.97% 100.00% 91.38% 6.49% 100.00% 91.69%
<29 4.70% 99.98% 91.52% 1.79% 100.00% 91.27% 4.98% 100.00% 91.56%
<28 3.33% 99.99% 91.40% 1.03% 100.00% 91.20% 3.42% 100.00% 91.42%
<27 0.00% 100.00% 91.12% 0.00% 100.00% 91.12% 0.00% 100.00% 91.12%
AUC, area under the curve.
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